ConductScience.org, home

Trial · NCT04972656

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of diagnostic PAH (mPAP ≥25 mmHg)baseline, 1 year
Determine whether mean pulmonary arterial pressure of patients with borderline - PAH (mPAP 21-24 mmHg) can be reduced by 3 mm Hg (absolute change baseline vs. 1 year; equals 15%) following treatment with ambrisentan 10 mg/die (initiated with 5 mg/die and elevated up to 10 mg/die) over 1 year (primary endpoint) compared to baseline and placebo.
PrimaryChange of Pulmonary vascular resistancebaseline, 1 yearPulmonary vascular resistance by right heart catheterization
SecondaryRe-hospitalization due to clinical worseningbaseline, 3 years
Re-hospitalization is defined as clinical manifestations of worsening PAH requiring re-hospitalization in order to add intravenous pharmacological agents (inotrope or vasodilator), mechanical intervention or ultrafiltration, hemofiltration, or dialysis.
SecondaryAll-cause mortalitybaseline, 3 years
Secondary6-Minute-walking Testbaseline, 1 year
SecondaryRight atrial pressure by right heart catheterizationbaseline, 1 year
SecondaryCardiac output (CO) by right heart catheterizationbaseline, 1 year
SecondaryCardiac index (CI) by right heart catheterizationbaseline, 1 year
SecondaryRA-area (right atrial area) by echocardiographybaseline, 1 year
SecondaryRV-area (right ventricular area) by echocardiographybaseline, 1 year
SecondaryTei by echocardiographybaseline, 1 yearTei
SecondaryTAPSE (tricuspid annular plane systolic excursion) by echocardiographybaseline, 1 year
SecondarysPAP (systolic pulmonary arterial pressure) by echocardiographybaseline, 1 year

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04972656/registered